Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes

Molecular Endocrinology

Volumn 15, Issue 6, 2001, Pages 909-922

  Bramlett, Kelli S ^a   Wu, Yifei ^a   Burris, Thomas P ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN RECEPTOR; LIGAND; RECEPTOR SUBTYPE;

AGONIST; ARTICLE; BINDING AFFINITY; DISSOCIATION CONSTANT; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING;

EID: 0034991013     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.15.6.0649     Document Type: Article

References (71)

1. The nuclear receptor superfamily
2. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
3. The nuclear receptor superfamily: The second decade
4. The RXR heterodimers and orphan receptors
5. Coactivators and corepressors
6. Nuclear receptors coactivators: Cellular and molecular biology
7. Coactivation and corepression in transcriptional regulation by steroid/nuclear hormone receptors
8. Estrogen receptor-associated preteins: Possible mediators of hormone-induced transcription
9. Sequence and characterization of a coactivator for the steroid receptor superfamily
10. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domain of steroid receptors
11. GRIP1, a transriptional coactivator for the AF2 transactivation domain of steroid, thyroid, retinoid and vitamin D receptors
12. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function of AF-2 of nuclear receptors
13. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
14. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
15. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF-2
16. TRAM-1, a novel 160 kDa thyroid hormone receptor activator molecule exhibits distinct properties from steroid receptor coactivator-1
17. The transcriptional coactivator p/CIP binds CBP and mediates nuclear-receptor function
18. A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity
19. A signature motif in transcriptional coactivators mediates binding to nuclear receptors
20. Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator
21. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
22. Specific structural motifs determine TRAP220 interactions with nuclear hormone receptors
23. Thyroid hormone receptor-binding protein, an LXXLL motif-containing protein, functions as a general coactivator
24. Modulation of estrogen receptor-α transcriptional activity by the coactivator PGC-1
25. The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes
26. Cloning and characterization of RAP250, a novel nuclear receptor coactivator
27. Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor
28. A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo
29. A canonical structure for the ligand-binding domain of nuclear receptors
30. The nuclear receptor ligand-binding domain: Structure and function
31. Nuclear-receptor ligands and ligand-binding domains
32. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors
33. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor γ
34. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
35. Structure and specificity of nuclear receptor-coactivator interactions
36. Molecular determinants of the estrogen receptor-coactivator interface
37. Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor
38. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities
39. Mechanistic principles in NR box-dependent interaction between nuclear hormone receptors and the coactivator TIF2
40. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: Discovery of peptide antagonists of estrogen receptors α and β
41. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways
42. Selection of estrogen receptor β and thyroid hormone receptor β specific coactivator mimetic peptides using recombinant peptide libraries
43. Determinates of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation
44. Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog
45. Molecular basis of agonism and antagonism in the oestrogen receptor
46. Structure of the ligand-binding domain of oestrogen receptor β in the presence of a partial agonist and a full agonist
47. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains
48. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens
49. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor
50. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor
51. Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists
52. Differential interaction of the methoxychlor metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane with estrogen receptors α and β
53. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
54. The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties
55. An ultrahigh-throughput screening assay for estrogen receptor ligands
56. ERβ: Identification and characterization of a novel human estrogen receptor
57. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
58. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene
59. Mice deficient in the steroid receptor coactivator 1 (SRC-1) are resistant to thyroid hormone
60. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development
61. Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor γ (PPARγ) heterodimers: Intermolecular synergy requires only the PPARγ hormone-dependent activation function
62. Nuclear receptors have distinct affinities for coactivators: Characterization by fluorescence resonance energy transfer
63. p300 functions as a coactivator for the peroxisome proliferator-activated receptor a
64. Differential interaction of steroid hormone receptors with LXXLL motifs in SRC-1 depends on residues flanking the motif
65. The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogen
66. Differential expression and regional distribution of steroid receptor coactivators SRC-1 and SRC-2 in brain and pituitary
67. Expression of estrogen receptor-β messenger ribonucleic acid in oxytocin and vasopressin neurons of the rat supraoptic and paraventricular nuclei
68. Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system
69. Development of peptide antagonists that target estrogen receptor-β interactions
70. Ligand type-specific interactions of peroxisome proliferator-activated receptor y with transcriptional coactivators
71. 3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia